Compass Therapeutics Correlations

CMPX Stock

USD 6.42 0.02 0.31%

The current 90-days correlation between Compass Therapeutics and Fulcrum Therapeutics is 0.01 (i.e., Significant diversification). The correlation of Compass Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Compass Therapeutics Correlation With Market

Very weak diversification

The correlation between Compass Therapeutics and DJI is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Compass Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Moving together with Compass Stock

0.72	VRTX	Vertex Pharmaceuticals Earnings Call Tomorrow	Pair Corr
0.61	VYNE	Vyne Therapeutics	Pair Corr
0.64	KOD	Kodiak Sciences	Pair Corr
0.66	GILD	Gilead Sciences Earnings Call This Week	Pair Corr
0.72	NRIX	Nurix Therapeutics	Pair Corr
0.66	PLRZ	Polyrizon Ordinary	Pair Corr

Moving against Compass Stock

0.91	XGN	Exagen Inc	Pair Corr
0.81	ENSC	Ensysce Biosciences	Pair Corr
0.8	EDIT	Editas Medicine	Pair Corr
0.77	HURA	TuHURA Biosciences	Pair Corr
0.73	AIM	AIM ImmunoTech	Pair Corr
0.72	JSPR	Jasper Therapeutics	Pair Corr
0.7	CUE	Cue Biopharma	Pair Corr
0.62	MDXH	MDxHealth SA ADR	Pair Corr
0.59	DYN	Dyne Therapeutics	Pair Corr
0.54	XBIO	Xenetic Biosciences	Pair Corr
0.41	INTS	Intensity Therapeutics	Pair Corr
0.4	VIVS	VivoSim Labs Symbol Change	Pair Corr
0.4	KURA	Kura Oncology	Pair Corr
0.84	AKAN	Akanda Corp	Pair Corr
0.78	PROK	ProKidney Corp	Pair Corr
0.74	OGEN	Oragenics	Pair Corr
0.72	PCSA	Processa Pharmaceuticals	Pair Corr
0.71	NTRB	Nutriband	Pair Corr
0.68	NRXP	NRX Pharmaceuticals	Pair Corr
0.64	ADXN	Addex Therapeutics	Pair Corr
0.52	PSTV	Plus Therapeutics	Pair Corr
0.44	PLUR	Pluri Inc	Pair Corr

Related Correlations Analysis

	FULC	FDMT	OCGN	BCYC	GOSS	LXRX	MNPR	CRVS	KALV	OMER
FULC		-0.17	-0.14	0.15	0.71	-0.26	-0.28	0.09	0.7	0.4	FULC
FDMT	-0.17		-0.57	0.4	0.18	0.32	0.82	-0.22	-0.54	-0.76	FDMT
OCGN	-0.14	-0.57		-0.02	-0.56	-0.09	-0.51	0.27	0.1	0.28	OCGN
BCYC	0.15	0.4	-0.02		0.19	0.07	0.26	-0.06	-0.11	-0.14	BCYC
GOSS	0.71	0.18	-0.56	0.19		-0.16	0.06	-0.21	0.48	0.11	GOSS
LXRX	-0.26	0.32	-0.09	0.07	-0.16		0.49	0.57	-0.28	-0.36	LXRX
MNPR	-0.28	0.82	-0.51	0.26	0.06	0.49		-0.2	-0.66	-0.73	MNPR
CRVS	0.09	-0.22	0.27	-0.06	-0.21	0.57	-0.2		0.22	0.14	CRVS
KALV	0.7	-0.54	0.1	-0.11	0.48	-0.28	-0.66	0.22		0.67	KALV
OMER	0.4	-0.76	0.28	-0.14	0.11	-0.36	-0.73	0.14	0.67		OMER
	FULC	FDMT	OCGN	BCYC	GOSS	LXRX	MNPR	CRVS	KALV	OMER

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MNPR	+ 0.82	FDMT
GOSS	+ 0.71	FULC
KALV	+ 0.7	FULC
OMER	+ 0.67	KALV
CRVS	+ 0.57	LXRX
MNPR	+ 0.49	LXRX

High negative correlations

OMER	- 0.76	FDMT
OMER	- 0.73	MNPR
KALV	- 0.66	MNPR
OCGN	- 0.57	FDMT
GOSS	- 0.56	OCGN
KALV	- 0.54	FDMT

Risk-Adjusted Indicators

There is a big difference between Compass Stock performing well and Compass Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Compass Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FULC	4.44	0.42	0.06	(0.22)	4.52	(5.23)	11.56	(7.84)	53.80
FDMT	3.84	(0.32)	0.00	(0.28)	0.00	0.00	6.52	(9.30)	27.09
OCGN	3.69	0.05	(0.01)	0.00	4.40	(4.36)	7.25	(7.43)	32.50
BCYC	2.88	(0.33)	0.00	(0.45)	0.00	0.00	6.06	(6.93)	17.28
GOSS	3.82	0.11	0.02	0.12	4.73	(3.89)	8.77	(6.57)	27.11
LXRX	3.94	(0.11)	0.00	0.01	5.41	(4.68)	9.86	(8.97)	38.53
MNPR	2.93	(0.25)	0.00	(0.69)	0.00	0.00	5.46	(6.48)	20.65
CRVS	6.47	2.39	0.64	0.62	2.87	(8.62)	9.63	(6.97)	174.29
KALV	3.14	0.61	0.14	(1.01)	3.11	(3.48)	8.43	(5.92)	25.15
OMER	5.61	1.03	0.19	6.56	4.44	(6.85)	12.62	(7.99)	87.69

Compass Therapeutics Corporate Management

Susan Kalled	Chief Officer	Profile
Cynthia MD	Chief Officer	Profile
Anna Gifford	Communications Manager	Profile
Karin BA	Senior Operations	Profile
Vered MBA	Pres COO	Profile
MBA JD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC